Researchers have found that a long-acting injection, given just twice a year alongside standard drugs. Blood pressure is one of the most common health problems worldwide, yet it remains difficult to ...

Zilebesiran, an interfering RNA, administered every 3-6 months lowers blood pressure in patients with mild to moderate hypertension. For patients with mild to moderate hypertension, a single injection ...

A single subcutaneous injection of the investigational drug zilebesiran, when added to existing treatment with a standard antihypertensive medication, reduced systolic blood pressure by between 4 to ...

A single injection of the investigational antihypertensive agent zilebesiran (Alnylam Pharmaceuticals) effectively lowered blood pressure in adults with mild to moderate hypertension for up to 6 ...

ProvideGx, a company established by Premier in January to address generic drug shortages, will start with manufacturing a blood pressure medication that has been hard to obtain. The company, a ...

Learn how zinc affects blood vessel function, what research shows about zinc supplements and blood pressure, and who may or may not benefit.

Results from a clinical trial led by researchers from Queen Mary University of London, published today in JAMA, show that giving people with high blood pressure an injection every six months can lead ...